Verification of the Quantitative Accuracy of the PET/CT System Imaging Chain



Status:Not yet recruiting
Healthy:No
Age Range:40 - Any
Updated:4/2/2016
Start Date:November 2012

Use our guide to learn which trials are right for you!

ROMAN (PCA-9000A) PET/CT System Verification

The purpose of this study will evaluate new technologies that have been included in the new
PCA-9000A PET/CT System.

Scope:

To evaluate the new technologies that have been included in the PCA-9000A PET/CT System, the
study has the following 3 goals.

- Define and confirm all supported clinical protocols from Low-Dose CT, to PET
acquisition and presentation.

- Verification of the quantitative accuracy of the imaging chain.

- Evaluate the performance and stability of the new system and its related quality
control and calibration procedures.

Result (Expected):

The study is an essential step in assessing the quality of the hardware and software
defining the new PCA-9000A PET/CT System. Several essential parameters for the acquisition,
reconstruction, correction, filtering, and presentation will be estimated or adjusted during
this period. The evaluation will confirm PCA-9000A PET/CT System is effective for its
intended use.

Inclusion:

- Patients already scheduled for an FDG test at SDMI

- 40 years and older

- Adult must be able to sign an informed consent form

Exclusion

- Patients not scheduled for an FDG test at SDMI

- 39 years or younger

- Pregnant adult female or plan to be pregnant

- Adult who is unable to sign the informed consent
We found this trial at
1
site
?
mi
from
Henderson, NV
Click here to add this to my saved trials